Cardiac Cardiac Total Anomalous Pulmonary Venous Return (TAPVR) myxoma is the most common of the primary tumors of the adult heart, all of which are very rare. Cardiac Cardiac Total Anomalous Pulmonary Venous Return (TAPVR) myxoma is a benign Benign Fibroadenoma neoplasm that arises from primitive multipotent mesenchymal cells. Most occur sporadically, but some are a part of some familial syndromes. All 4 chambers may give rise to myxoma, but 90% originate and grow in the atria, with a left-to-right ratio of approximately 4:1. Diagnosis is made by echocardiography Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Tricuspid Valve Atresia (TVA), cardiac Cardiac Total Anomalous Pulmonary Venous Return (TAPVR) magnetic resonance imaging (MRI), or cardiac Cardiac Total Anomalous Pulmonary Venous Return (TAPVR) computed tomography (CT). Complete surgical excision is required because of the substantial risk of embolization Embolization A method of hemostasis utilizing various agents such as gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and intracranial arteriovenous malformations, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Gastrointestinal Bleeding and cardiovascular complications, including sudden death.
Last updated: Jan 8, 2021
Sign up now and get free access to Lecturio with concept pages, medical videos, and questions for your medical education.
Lecturio Premium gives you full access to all content & features
Verify your email now to get a free trial.
Lecturio Premium gives you full access to all contents and features—including Lecturio’s Qbank with up-to-date board-style questions.